FDA To Fill Frankos' Shoes As Major Dietary Supplement Initiatives Pend
This article was originally published in The Tan Sheet
Executive Summary
The successor to Vasilios "Bill" Frankos, FDA's director of Dietary Supplement Programs, will face a full plate of imminent and ongoing regulatory issues
You may also be interested in...
FDA Interim Supplement Chief Spiller Has Deputy Commissioner Experience
Philip Spiller, a 29-year FDA veteran and a one-time deputy commissioner, heads the agency's dietary supplement office on an interim basis with industry support for a permanent appointment to the post
GAO New Dietary Ingredient Probe Has Puzzled Firms Seeking Legal Advice
A Government Accountability Office investigation asking dietary supplement firms questions about new dietary ingredient status has left stakeholders puzzled and calling their counsel
Herbalife Hires FDA's Frankos For Compliance/Safety Position
Herbalife will have a leg up in terms of compliance with good manufacturing practice and adverse event reporting requirements with its planned addition of FDA's Vasilios "Bill" Frankos